0.05Open0.05Pre Close0 Volume280 Open Interest140.00Strike Price0.00Turnover235.92%IV83.29%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.0087Delta0.0013Gamma1528.20Leverage Ratio-0.0386Theta0.0001Rho13.30Eff Leverage0.0019Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet